Nasdaq
KYMR
Kymera Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.9%
- 1 month
- −10.8%
- 1 year
- +157%
$106.41 · Mkt cap $8.75B
At the 6 Aug 2026 close
Nasdaq
Kymera Therapeutics, Inc.
$106.41 · Mkt cap $8.75B
At the 6 Aug 2026 close
Kymera Therapeutics, Inc. trades under the ticker KYMR on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $8.75B. The last closing price was $106.41, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +157%, and −10.8% over the past month. Returns are price returns and exclude dividends.
This page exists because KYMR is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.